Chiesi Ventures β Full Portfolio
9 tracked investments Β· listed companies and verified rows first
BiotechEmeryville, US
David Kirn(Executive Officer, Director)David Schaffer(Director)Theresa Janke(Executive Officer)
BoardSharon Tetlow(Director)Margi McLoughlin(Director)
Aura Biosciences develops Virus-Like Drug Conjugates (VDCs), a platform using Virus-Like Particles conjugated with drugs or loaded with nucleic acids to target solid tumors.
BiotechHealthtechMedical DevicesCambridge, US
Elisabet de los Pinos, Ph.D.(Executive Officer, Director)Michael Wyzga(Executive Officer)Dale Pfost, Ph.D.(Director)Alan E. Walts, Ph.D.(Director)Lewis Geffen(Executive Officer)Peter Wirth(Director)
Rare liver disease treatment company.
San Diego, US
Chris Peetz(Founder)in
Developing therapies for congenital disorders of glycosylation combining replacement therapies with intracellular delivery vehicles.
San Francisco, US
Board seatGiacomo ChiesiΒ· per SEC Form D
Discovering and developing therapies for neurodegenerative diseases including Parkinson's and Alzheimer's.
BiotechSouth San Francisco, US
John F. Fowler(Executive Officer, Director)Christopher J. Kirk(Executive Officer, Director)
BoardDr. Gerald Chan(Director)Dr. Jean-Pierre Sommadossi(Director)
Minoryx is a biopharmaceutical company that discovers and develops drug treatments for severe orphan diseases of the central nervous system, such as cerebral adrenoleukodystrophy and Rett syndrome.
BiotechHealthtech
BiotechMedford, US
Biju Parekkadan(Director)Brian Miller(Executive Officer, Director)
BoardMartin Heidecker(Director)Greg Bailey(Director)Rich Ganz(Director)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.